MolNFT v1 · #62731 · protein
Crystal structure the Fab fragment of efalizumab in complex with lfa-1 I domain, form I
3EOA: “Crystal structure the Fab fragment of efalizumab in complex with lfa-1 I domain, form I”. X-ray diffraction. MolNFT v1 #62731 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 3EOA
- Type
- protein
- Length
- 1,216 residues
- Chains
- 6
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P20701
Structure
x-ray diffraction · 3 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| L, A | — | protein | 214 | — | — |
| H, B | — | protein | 215 | — | — |
| I, J | — | protein | 179 | — | P20701 |
Compared structures
- 3EOA · Crystal structure the Fab fragment of Efalizumab in complex with LFA-1 I domain, Form I · the same entry in another collection · chain I against I, TM-score 1.00
- P20701 · AlphaFold monomer V2.0 prediction for integrin alpha-L (P20701) · a predicted model of the same protein · chain I against A, TM-score 0.98
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P20701
- Elsewhere: RCSB PDB 3EOA · PDBe 3EOA · UniProt P20701
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.